Single nucleotide polymorphism rs10889677 in miRNAs Let-7e and Let-7f binding site of IL23R gene is a strong colorectal cancer determinant: Report and meta-analysis.

[1]  Sharifeh Khosravi,et al.  Environmental Risk Factors Associated with Sporadic Colorectal Cancer in Isfahan, Iran , 2018 .

[2]  Sharifeh Khosravi,et al.  Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant. , 2018, Journal of gastrointestinal oncology.

[3]  A. Feizi,et al.  Single nucleotide polymorphism rs696 in miR449a binding site of NFKBIA gene is correlated with risk of colorectal cancer , 2018, Gastroenterology and hepatology from bed to bench.

[4]  Sharifeh Khosravi,et al.  Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians , 2017, Advanced biomedical research.

[5]  Y. Li,et al.  SNP-SNP interactions of three new pri-miRNAs with the target gene PGC and multidimensional analysis of H. pylori in the gastric cancer/atrophic gastritis risk in a Chinese population , 2016, Oncotarget.

[6]  J. Rioux,et al.  IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking* , 2016, The Journal of Biological Chemistry.

[7]  Linbo Gao,et al.  Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. , 2015, Genetics and molecular research : GMR.

[8]  R. Malekzadeh,et al.  Simultaneous Underexpression of let-7a-5p and let-7f-5p microRNAs in Plasma and Stool Samples from Early Stage Colorectal Carcinoma , 2015, Biomarkers in cancer.

[9]  R. Purohit,et al.  Single Nucleotide Polymorphisms in MicroRNA Binding Sites: Implications in Colorectal Cancer , 2014, TheScientificWorldJournal.

[10]  P. Zhang,et al.  Association between polymorphisms in the integrin gene predicted microRNA binding sites and bladder cancer risk. , 2014, International journal of clinical and experimental medicine.

[11]  Liqing Zhou,et al.  A Functional TNFAIP2 3'-UTR rs8126 Genetic Polymorphism Contributes to Risk of Esophageal Squamous Cell Carcinoma , 2014, PloS one.

[12]  R. Salehi,et al.  A miRNA-binding site single nucleotide polymorphism in the 3′-UTR region of the NOD2 gene is associated with colorectal cancer , 2014, Medical Oncology.

[13]  D. A. Anand,et al.  BINDING SITE ANALYSIS OF MICRORNAS TARGET INTERACTION FROM GENOME WIDE ASSOCIATION STUDIES , 2014 .

[14]  Hui Xue,et al.  Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese , 2014, Familial Cancer.

[15]  M. De la Fuente,et al.  Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.

[16]  Y. Bignon,et al.  Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer. , 2014, Immunology letters.

[17]  Shaomu Chen,et al.  Functional Polymorphisms in Interleukin-23 Receptor and Susceptibility to Esophageal Squamous Cell Carcinoma in Chinese Population , 2014, PloS one.

[18]  Yunzhi Chen,et al.  Functional IL-23R rs10889677 Genetic Polymorphism and Risk of Multiple Solid Tumors: a Meta-Analysis , 2013, PloS one.

[19]  M. Smyth,et al.  A balance of interleukin-12 and -23 in cancer. , 2013, Trends in immunology.

[20]  A. Naccarati,et al.  Variation within 3′-UTRs of Base Excision Repair Genes and Response to Therapy in Colorectal Cancer Patients: A Potential Modulation of microRNAs Binding , 2013, Clinical Cancer Research.

[21]  Z. Li,et al.  A let-7 binding site polymorphism rs712 in the KRAS 3′ UTR is associated with an increased risk of gastric cancer , 2013, Tumor Biology.

[22]  Kai Li,et al.  Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor. , 2013, Carcinogenesis.

[23]  W. Liu,et al.  A miRNA Binding Site Single-Nucleotide Polymorphism in the 3′-UTR Region of the IL23R Gene Is Associated with Breast Cancer , 2012, PloS one.

[24]  Yifeng Zhou,et al.  Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. , 2012, Carcinogenesis.

[25]  Dai Zhang,et al.  MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs , 2012, BMC Genomics.

[26]  H. Sorbye,et al.  Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab , 2012, BMC Cancer.

[27]  B. Bogen,et al.  A model for cancer-suppressive inflammation , 2012, Oncoimmunology.

[28]  W. Guo,et al.  Protection against Th17 Cells Differentiation by an Interleukin-23 Receptor Cytokine-Binding Homology Region , 2012, PloS one.

[29]  Junbo Hu,et al.  Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study , 2012, BMC Cancer.

[30]  R. Salehi,et al.  Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population , 2012, Medical Oncology.

[31]  Krista A. Zanetti,et al.  3'-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African Americans. , 2012, Cancer research.

[32]  T. Wurdinger,et al.  Cutting Edge: A Variant of the IL-23R Gene Associated with Inflammatory Bowel Disease Induces Loss of MicroRNA Regulation and Enhanced Protein Production , 2012, The Journal of Immunology.

[33]  R. Weber,et al.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. , 2011, Carcinogenesis.

[34]  P. A. van den Brandt,et al.  A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer , 2011, Clinical Cancer Research.

[35]  L. Fan,et al.  Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility , 2011, PLoS genetics.

[36]  Jianping Wang,et al.  NFκB1 and NFκBIA Polymorphisms Are Associated with Increased Risk for Sporadic Colorectal Cancer in a Southern Chinese Population , 2011, PloS one.

[37]  Jun Yu,et al.  IL23R +2199A/C polymorphism is associated with decreased risk of certain subtypes of gastric cancer in Chinese: a case-control study. , 2011, Cancer epidemiology.

[38]  Nikolaus Rajewsky,et al.  The Impact of miRNA Target Sites in Coding Sequences and in 3′UTRs , 2011, PloS one.

[39]  E. Bottini,et al.  A Study of Three Polymorphic Sites of ADA Gene in Colon Cancer , 2010, Cancer investigation.

[40]  Michael Karin,et al.  Inflammation and colon cancer. , 2010, Gastroenterology.

[41]  Amir Reza Radmard,et al.  Five common cancers in Iran. , 2010, Archives of Iranian medicine.

[42]  Bin Zhou,et al.  Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer. , 2010, Cancer genetics and cytogenetics.

[43]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[44]  Brock C Christensen,et al.  A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. , 2009, Carcinogenesis.

[45]  V. Kuchroo,et al.  Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells1 , 2009, The Journal of Immunology.

[46]  J. Bertino,et al.  MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. , 2009, Pharmacogenomics.

[47]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[48]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[49]  D. Banerjee,et al.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics , 2008, Cell cycle.

[50]  K. Hemminki,et al.  Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. , 2007, Carcinogenesis.

[51]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[52]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[53]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[54]  H. Yarmohammadi,et al.  Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980−2000 , 2004, ANZ journal of surgery.

[55]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[56]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[57]  T. Mcclanahan,et al.  A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.

[58]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[59]  Ming Yang,et al.  Interleukin-23 receptor genetic variants contribute to susceptibility of multiple cancers. , 2014, Gene.

[60]  J. Weidhaas,et al.  SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer. , 2013, Pharmacology & therapeutics.

[61]  Z. Li,et al.  A let-7 KRAS rs712 polymorphism increases colorectal cancer risk , 2013, Tumor Biology.

[62]  R. Kastelein,et al.  Understanding the IL-23-IL-17 immune pathway. , 2006, Trends in immunology.